Clinical Trials Directory

Trials / Completed

CompletedNCT01394978

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
444 (actual)
Sponsor
C. R. Bard · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.

Detailed description

Patients having open thoracotomy involving lung resection surgery will be considered for the study. Subjects will be examined for adverse events and complications from either the treatment or the procedure. Follow-up visits are required at 30 days and 90 days after the surgery.

Conditions

Interventions

TypeNameDescription
OTHERControlStandard surgical techniques including staples and sutures.
DEVICEProGEL Pleural Air Leak Sealant with standard surgical closureProGEL is a single-use medical device that is formed as a result of mixing two components: (1) a solution of human serum albumin (HSA) and (2) a synthetic cross-linking component of polyethylene glycol (PEG). Standard closure means, for example, suturing or stapling of visible air leaks incurred during resection of lung parenchyma.
DEVICEProGEL Pleural Air Leak Sealant without standard surgical closureProGEL is a single-use medical device that is formed as a result of mixing two components: (1) a solution of human serum albumin (HSA) and (2) a synthetic cross-linking component of polyethylene glycol (PEG). Standard closure means, for example, suturing or stapling of visible air leaks incurred during resection of lung parenchyma.

Timeline

Start date
2011-06-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2011-07-15
Last updated
2021-07-15
Results posted
2017-07-11

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01394978. Inclusion in this directory is not an endorsement.